SCHEMBL7562364

SCHEMBL7562364

C1=C(c2ccc3c4c(cccc24)CC3)CC(Cc2ccccc2)NC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
ALDH1A1 P00352 5/20 0.35
KMT2A Q03164 4/20 0.35
HPGD P15428 4/20 0.35
MEN1 O00255 3/20 0.35
POLB P06746 2/20 0.35
GAA P10253 2/20 0.35
ATM Q13315 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
SLC22A1 O15245 1/20 0.34
PRCP P42785 1/20 0.34
MAPT P10636 3/20 0.33
KDM4E B2RXH2 3/20 0.33
LMNA P02545 2/20 0.33
MCL1 Q07820 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
GRIN2B Q13224 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.30
CYP3A4 P08684 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8368017 0.81 SLC6A3 (0.37) ALDH1A1KMT2AHPGDMEN1POLB
SCHEMBL5265951 0.76 POLB (0.44) KMT2AMEN1POLBSLC22A1PRCP
SCHEMBL7560334 0.73 POLB (0.39) KMT2AMEN1POLBATM
SCHEMBL7444323 0.70 POLB (0.41) ALDH1A1KMT2AMEN1POLBSMN1; SMN2
SCHEMBL6961333 0.70 POLB (0.39) KMT2AMEN1POLB
SCHEMBL5543765 0.70 POLB (0.39) KMT2AMEN1POLBTDP1CYP3A4
SCHEMBL6504166 0.70 POLB (0.34) ALDH1A1KMT2AMEN1POLBMAPT
SCHEMBL7844747 0.70 CDK9 (0.35) POLB
SCHEMBL8312119 0.69 POLB (0.40) ALDH1A1KMT2AMEN1POLB
SCHEMBL7561336 0.68 MEN1 (0.41) ALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002076440-A2 METHODS OF TREATING ALZHEIMER'S DISEASE WITH PIPERIDIN DERIVATES ELAN PHARMACEUTICALS, INC. (US) 2002-10-03 WO disclosed